Successful Therapy of Refractory Pyoderma Gangrenosum and Periorbital Phlegmona With Tacrolimus (FK506) in Ulcerative Colitis

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract:

We describe two male patients with ulcerative colitis and refractory pyoderma gangrenosum including periorbital phlegmona in one case. Both patients were successfully managed with low dose oral tacrolimus (0.1 mg/kg bodyweight per day). Serum trough levels were closely monitored and maintained between 4 and 6 ng/mL. A rapid response was noted in both cases. Complete non-scarring skin restitution without side effects was accomplished in both cases. Low dose oral tacrolimus provides a valuable alternative treatment option for IBD patients with refractory pyoderma gangrenosum.

Related Topics

    loading  Loading Related Articles